This assumption is confirmed by the fact that a significant increase of the amount of bacterial lipopolysaccharide (LPS), and soluble sCD14 receptor associated with elevated systemic levels of IL-6, TNF-α, CCL5/RANTES and CCL2/MCP-1 was observed in critically ill patients with COVID-19 [112]. The gene discussed is CCL2; the disease is COVID-19.